EMA's Lönngren turns strategic advisor with NDA
This article was originally published in Scrip
Executive Summary
Dr Thomas Lönngren, former executive director of the European Medicines Agency, has been appointed strategic advisor of consulting group NDA's new UK-based business, NDA Advisory Services. Dr Lönngren will play a "fundamental role" in the market access aspect of the business, NDA confirmed. This will include encouraging a push for HTA harmonisation and advising on regulatory strategy, Dr Lönngren added. He left the EMA following a 10-year term at the end of last year.